Therapeutic potential of stem cells in addressing female infertility: recent progress and prospective developments - Takeaways - MDSpire

Therapeutic potential of stem cells in addressing female infertility: recent progress and prospective developments

  • By

  • Yuyi Wu

  • Siying Chen

  • Ruotong Hao

  • Ruipeng Wang

  • Liandi Mai

  • July 6, 2026

  • 0 min

Share

  • 1

    Female infertility affects 10–15% of women of reproductive age and is often due to ovarian insufficiency and endometrial damage.

  • 2

    Stem cell therapies show promise in improving ovarian function and endometrial receptivity through mechanisms like paracrine signaling and immunomodulation.

  • 3

    Mesenchymal stem cells (MSCs) are the most researched type for infertility, with sources including bone marrow and umbilical cord.

  • 4

    Induced pluripotent stem cells (iPSCs) can differentiate into various cell types and have potential for artificial gametogenesis.

  • 5

    Current clinical research favors MSCs due to their higher safety profiles and fewer ethical concerns compared to embryonic stem cells.

Original Source(s)

Therapeutic potential of stem cells in addressing female infertility: recent progress and prospective developments

  • by Yuyi Wu, Siying Chen, Ruotong Hao, Ruipeng Wang, Liandi Mai

  • July 6, 2026

Related Content

Perspectives on periviable birth from the parents of surviving infants

Phototoxicity of brightfield live-cell imaging on murine ovarian follicles

Informed consent in medically assisted procreation in Italy: medico-legal and ethical challenges shaping physician responsibility